Belastungsuntersuchungen in der Pneumologie

F. J. Meyer; M. M. Borst; H. C. Buschmann; R. Ewert; B. Friedmann-Bette; U. Ochmann; W. Petermann; A. M. Preisser; D. Rohde; K.-H. Rühle; S. Sorichter; G. Stähler; M. Westhoff; H. Worth

doi:10.1055/s-0032-1325901

Pneumologie 2013; 67(01): 16-34
DOI: 10.1055/s-0032-1325901

Empfehlungen

Belastungsuntersuchungen in der Pneumologie

Empfehlungen der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V.Exercise Testing in Respiratory MedicineDGP Recommendations

F. J. Meyer^*

¹Klinik für Pneumologie, Gastroenterologie, Internistische Intensiv- und Beatmungsmedizin, Städtisches Klinikum Harlaching, München

,

M. M. Borst

²Medizinische Klinik I, Caritas-Krankenhaus, Bad Mergentheim

,

H. C. Buschmann

³Klinik für Pneumologie und Allgemeine Innere Medizin, Brüderkrankenhaus St. Josef Paderborn

,

R. Ewert

⁴Klinik für Innere Medizin B; Bereich Pneumologie/Infektiologie, Universitätsmedizin, Greifswald

,

B. Friedmann-Bette

⁵Abt. Innere Medizin VII, Universitätsklinikum, Heidelberg

,

U. Ochmann

⁶Institut für Arbeits-, Sozial- und Umweltmedizin, Universitätsklinikum Innenstadt, München

,

W. Petermann

³Klinik für Pneumologie und Allgemeine Innere Medizin, Brüderkrankenhaus St. Josef Paderborn

,

A. M. Preisser

⁷Zentralinstitut für Arbeitsmedizin und Maritime Medizin, Universitätsklinikum Hamburg-Eppendorf, Hamburg

,

D. Rohde

⁸Abt. Innere Medizin III, Universitätsklinikum, Heidelberg

,

K.-H. Rühle

⁹HELIOS-Klinik Ambrock, Universität Witten-Herdecke, Hagen-Ambrock

,

S. Sorichter

¹⁰Abt. Pneumologie, Medizinische Universitätsklinik, Freiburg

,

G. Stähler

¹¹Medizinische Klinik I, Klinik Löwenstein, Löwenstein

,

M. Westhoff

¹²Klinik für Pneumologie, Lungenklinik, Hemer

,

H. Worth^*

¹³Medizinische Klinik I, Klinikum Fürth

› Institutsangaben

Abstract

Zusammenfassung

Dieses Dokument der DGP ersetzt die Empfehlungen von 1998. Anhand der aktuellen Datenlage und einer Konsensuskonferenz wurden Empfehlungen zu Indikationen, zur Auswahl und Durchführung der geeigneten Untersuchungstechniken sowie zu den technischen und personellen Voraussetzungen formuliert. Detaillierte Angaben werden zur Blutgasanalyse unter Belastung, zum 6-Minuten-Gehtest und Rechtsherzkatheter mit Belastung sowie zur Spiroergometrie und Stressechokardiografie gemacht. Der richtige Einsatz von Belastungsuntersuchungen bei anstrengungsinduziertem Asthma, bei sportmedizinischen bzw. arbeitsmedizinischen Fragestellungen, bei der präoperativen Risikostratifizierung und beim Therapiemonitoring pneumologischer Erkrankungen wird dargestellt.

Abstract

This document replaces the DGP recommendations published in 1998. Based on recent studies and a consensus conference, the indications, choice and performance of the adequate exercise testing method in its necessary technical and staffing setting are discussed. Detailed recommendations are provided: for arterial blood gas analysis and right heart catherterization during exercise, 6-minute walk test, spiroergometry, and stress echocardiography. The correct use of different exercise tests is discussed for specific situations in respiratory medicine: exercise induced asthma, monitoring of physical training or therapeutical interventions, preoperative risk stratification, and evaluation in occupational medicine.

Volltext

Referenzen

Literatur
1 ATS/ACCP. Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167: 211-277
2 Palange P, Ward SA, Carlsen KH et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007; 29: 185-209
3 Balady GJ, Arena R, Sietsema K et al. Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010; 122: 191-225
4 Worth H, Breuer H-W et al. Deutsche Gesellschaft für Pneumologie: Empfehlungen zur Durchführung und Bewertung von Belastungsuntersuchungen in der Pneumologie. Pneumologie 1998; 52: 225-231
5 Magnussen H, Kirsten AM, Kohler D et al. [Guidelines for long-term oxygen therapy. German Society for Pneumology and Respiratory Medicine]. Pneumologie 2008; 62: 748-756
6 Keteyian SJ, Isaac D, Thadani U et al. Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction. Am Heart J 2009; 158: S72-S77
7 Gibbons RJ, Balady GJ, Bricker JT et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002; 106: 1883-1892
8 Miyamura M, Honda Y. Oxygen intake and cardiac output during maximal treadmill and bicycle exercise. J Appl Physiol 1972; 32: 185-188
9 Christensen CC, Ryg MS, Edvardsen A et al. Effect of exercise mode on oxygen uptake and blood gases in COPD patients. Respir Med 2004; 98: 656-660
10 Buchfuhrer MJ, Hansen JE, Robinson TE et al. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol 1983; 55: 1558-1564
11 Hsia D, Casaburi R, Pradhan A et al. Physiological responses to linear treadmill and cycle ergometer exercise in COPD. Eur Respir J 2009; 34: 605-615
12 Mathur RS, Revill SM, Vara DD et al. Comparison of peak oxygen consumption during cycle and treadmill exercise in severe chronic obstructive pulmonary disease. Thorax 1995; 50: 829-833
13 Bonzheim SC, Franklin BA, DeWitt C et al. Physiologic responses to recumbent versus upright cycle ergometry, and implications for exercise prescription in patients with coronary artery disease. Am J Cardiol 1992; 69: 40-44
14 Hughes JMB. Physiology and practice of pulmonary function. West Midlands: Association for respiratory technology and physiology (ARTP); 2009
15 Löllgen H, Erdmann E, Gitt A. Ergometrie. 3.. ed. Heidelberg: Springer Verlag; 2011
16 Wasserman K, Hansen JE, Sue DY et al. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. 5.. ed. Philadelphia: Lippincott, Williams & Wilkins; 2011
17 Debigare R, Maltais F, Mallet M et al. Influence of work rate incremental rate on the exercise responses in patients with COPD. Med Sci Sports Exerc 2000; 32: 1365-1368
18 Revill SM, Beck KE, Morgan MD. Comparison of the peak exercise response measured by the ramp and 1-min step cycle exercise protocols in patients with exertional dyspnea. Chest 2002; 121: 1099-1105
19 Benzo RP, Paramesh S, Patel SA et al. Optimal protocol selection for cardiopulmonary exercise testing in severe COPD. Chest 2007; 132: 1500-1505
20 Glaser S, Lodziewski S, Koch B et al. Influence of the incremental step size in work rate on exercise response and gas exchange in patients with pulmonary hypertension. BMC Pulm Med 2008; 8: 3
21 Naughton JP, Balke B, Nagle FJ. Refinements in methods of evaluation and physical conditioning before and after myocardial infarction. Am J Cardiol 1964; 14: 837-843
22 Bruce RA, McDonough JR. Stress testing in screening for cardiovascular disease. Bull N Y Acad Med 1969; 45: 1288-1305
23 American College of Sports Medicine. ACSM' Guidelines for Exercise Testing and Prescription. Philadelphia: Lippincott, Williams and Wilkins; 2010
24 Midgley AW, Bentley DJ, Luttikholt H et al. Challenging a dogma of exercise physiology: does an incremental exercise test for valid VO2max determination really need to last between 8 and 12 minutes?. Sports Med 2008; 38: 441-447
25 Whipp BJ. Rate constant for the kinetics of oxygen uptake during light exercise. J Appl Physiol 1971; 30: 261-263
26 Nery LE, Wasserman K, Andrews JD et al. Ventilatory and gas exchange kinetics during exercise in chronic airways obstruction. J Appl Physiol 1982; 53: 1594-1602
27 Oga T, Nishimura K, Tsukino M et al. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.A comparison of three different exercise tests. Am J Respir Crit Care Med 2000; 161: 1897-1901
28 Casaburi R, Porszasz J. Constant work rate exercise testing: a tricky measure of exercise tolerance. COPD 2009; 6: 317-319
29 Puente-Maestu L, Villar F, Miguel J et al. Clinical relevance of constant power exercise duration changes in COPD. Eur Respir J 2009; 34: 340-345
30 Nagle FJ, Balke B, Naughton JP. Gradational step tests for assessing work capacity. J Appl Physiol 1965; 20: 745-748
31 Naughton JP, Hellerstein HK, Haider R. Methods of exercise testing. Exercise testing and exercise training in coronary heart disease. New York: Academic Press; 1973
32 Shephard RJ. Tests of maximum oxygen intake. A critical review. Sports Med 1984; 1: 99-124
33 Trappe HJ, Löllgen H. [Guidelines for ergometry. German Society of Cardiology--Heart and Cardiovascular Research]. Z Kardiol 2000; 89: 821-831
34 Koch B, Schaper C, Ittermann T et al. Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study. Eur Respir J 2009; 33: 389-397
35 Glaser S, Koch B, Ittermann T et al. Influence of age, sex, body size, smoking, and beta blockade on key gas exchange exercise parameters in an adult population. Eur J Cardiovasc Prev Rehabil 2010; 17: 469-476
36 Brown SE, Fischer CE, Stansbury DW et al. Reproducibility of VO2max in patients with chronic air-flow obstruction. Am Rev Respir Dis 1985; 131: 435-438
37 Marciniuk DD, Watts RE, Gallagher CG. Reproducibility of incremental maximal cycle ergometer testing in patients with restrictive lung disease. Thorax 1993; 48: 894-898
38 Meyer K, Westbrook S, Schwaibold M et al. Short-term reproducibility of cardiopulmonary measurements during exercise testing in patients with severe chronic heart failure. Am Heart J 1997; 134: 20-26
39 O'Donnell DE, Travers J, Webb KA et al. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J 2009; 34: 866-874
40 Hansen JE, Sun XG, Yasunobu Y et al. Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension. Chest 2004; 126: 816-824
41 Andersen KL, Shepard RJ, Denolin H et al. Fundamentals of exercise testing. Geneva: World Health Organisation; 1971: 138
42 Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381
43 Borg G. Anstrengungsempfinden. Dt Aerztebl 2004; 101: A1026-A1021
44 Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD 2005; 2: 105-110
45 Muza SR, Silverman MT, Gilmore GC et al. Comparison of scales used to quantitate the sense of effort to breathe in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 141: 909-913
46 Man WD, Mustfa N, Nikoletou D et al. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax 2004; 59: 471-476
47 O'Donnell DE, Fluge T, Gerken F et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-840
48 Chatila W, Nugent T, Vance G et al. The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease. Chest 2004; 126: 1108-1115
49 Hunt T, Williams MT, Frith P et al. Heliox, dyspnoea and exercise in COPD. Eur Respir Rev 2010; 19 (115) 30-38
50 Criner GJ, Belt P, Sternberg AL et al. Effects of lung volume reduction surgery on gas exchange and breathing pattern during maximum exercise. Chest 2009; 135: 1268-1279
51 Gigliotti F, Coli C, Bianchi R et al. Exercise training improves exertional dyspnea in patients with COPD: evidence of the role of mechanical factors. Chest 2003; 123: 1794-1802
52 Koppers RJ, Vos PJ, Boot CR et al. Exercise performance improves in patients with COPD due to respiratory muscle endurance training. Chest 2006; 129: 886-892
53 Rubin LJ, Badesch DB, Barst RJ et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002; 346: 896-903
54 Grant S, Aitchison T, Henderson E et al. A comparison of the reproducibility and the sensitivity to change of visual analogue scales, Borg scales, and Likert scales in normal subjects during submaximal exercise. Chest 1999; 116: 1208-1217
55 Dolmage TE, Hill K, Evans RA et al. Has my patient responded? Interpreting clinical measurements such as the 6-minute-walk test. Am J Respir Crit Care Med 2011; 184: 642-646
56 Enright PL, McBurnie MA, Bittner V et al. The 6-min walk test: a quick measure of functional status in elderly adults. Chest 2003; 123: 387-398
57 Camarri B, Eastwood PR, Cecins NM et al. Six minute walk distance in healthy subjects aged 55-75 years. Respir Med 2006; 100: 658-665
58 Huszczuk A, Whipp BJ, Wasserman K. A respiratory gas exchange simulator for routine calibration in metabolic studies. Eur Respir J 1990; 3: 465-468
59 Oudiz RJ, Barst RJ, Hansen JE et al. Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension. Am J Cardiol 2006; 97: 123-126
60 ATS. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-117
61 Turner SE, Eastwood PR, Cecins NM et al. Physiologic responses to incremental and self-paced exercise in COPD: a comparison of three tests. Chest 2004; 126: 766-773
62 Revill SM, Morgan MD, Singh SJ et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999; 54: 213-222
63 Brown CD, Benditt JO, Sciurba FC et al. Exercise testing in severe emphysema: association with quality of life and lung function. COPD 2008; 5: 117-124
64 Pepin V, Brodeur J, Lacasse Y et al. Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax 2007; 62: 291-298
65 Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD 2005; 2: 125-129
66 Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998; 158: 1384-1387
67 Gibbons WJ, Fruchter N, Sloan S et al. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 2001; 21: 87-93
68 Sciurba F, Criner GJ, Lee SM et al. Six-minute walk distance in chronic obstructive pulmonary disease: reproducibility and effect of walking course layout and length. Am J Respir Crit Care Med 2003; 167: 1522-1527
69 Hernandes NA, Wouters EF, Meijer K et al. Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J 2011; 38: 261-267
70 Demers C, McKelvie RS, Negassa A et al. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J 2001; 142: 698-703
71 Olsson LG, Swedberg K, Clark AL et al. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005; 26: 778-793
72 Miyamoto S, Nagaya N, Satoh T et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161: 487-492
73 Reesink HJ, van der Plas MN, Verhey NE et al. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg 2007; 133: 510-516
74 Modrykamien AM, Gudavalli R, McCarthy K et al. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis. Respir Care 2010; 55: 584-588
75 Lee WT, Peacock AJ, Johnson MK. The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension. Eur Respir J 2010; 36: 1294-1301
76 Reichenberger F, Voswinckel R, Enke B et al. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Eur Respir J 2007; 30: 922-927
77 Piazza G, Goldhaber SZ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2011; 364: 351-360
78 Piepoli MF. Exercise tolerance measurements in pulmonary vascular diseases and chronic heart failure. Respiration 2009; 77: 241-251
79 Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007; 132: 207-213
80 Flaherty KR, Andrei AC, Murray S et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006; 174: 803-809
81 Villalba WO, Sampaio-Barros PD, Pereira MC et al. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest 2007; 131: 217-222
82 Cardoso F, Tufanin AT, Colucci M et al. Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study. Chest 2007; 132: 477-482
83 Vogelmeier C, Buhl R, Criee CP et al. [Guidelines for the diagnosis and therapy of COPD issued by Deutsche Atemwegsliga and Deutsche Gesellschaft fur Pneumologie und Beatmungsmedizin]. Pneumologie 2007; 61: e1-e40
84 Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946
85 Casas A, Vilaro J, Rabinovich R et al. Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest 2005; 128: 55-61
86 Redelmeier DA, Bayoumi AM, Goldstein RS et al. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155: 1278-1282
87 Make B, Casaburi R, Leidy NK. Interpreting results from clinical trials: understanding minimal clinically important differences in COPD outcomes. COPD 2005; 2: 1-5
88 Puhan MA, Chandra D, Mosenifar Z et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J 2011; 37: 784-790
89 du Bois RM, Weycker D, Albera C et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med 2011; 183: 1231-1237
90 O'Keeffe ST, Lye M, Donnellan C et al. Reproducibility and responsiveness of quality of life assessment and six minute walk test in elderly heart failure patients. Heart 1998; 80: 377-382
91 Gilbert C, Brown MC, Cappelleri JC et al. Estimating a minimally important difference in pulmonary arterial hypertension following treatment with sildenafil. Chest 2009; 135: 137-142
92 Swigris JJ, Wamboldt FS, Behr J et al. The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax 2010; 65: 173-177
93 Lettieri CJ, Nathan SD, Browning RF et al. The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med 2006; 100: 1734-1741
94 Swigris JJ, Swick J, Wamboldt FS et al. Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest 2009; 136: 841-848
95 Palange P, Carlone S, Forte S et al. Cardiopulmonary exercise testing in the evaluation of patients with ventilatory vs circulatory causes of reduced exercise tolerance. Chest 1994; 105: 1122-1126
96 Kroidl RF, Schwarz S, Lehnigk B. Kursbuch Spiroergometrie. 2.. ed. Stuttgart: Thieme; 2009
97 Binder RK, Wonisch M, Corra U et al. Methodological approach to the first and second lactate threshold in incremental cardiopulmonary exercise testing. Eur J Cardiovasc Prev Rehabil 2008; 15: 726-734
98 Wasserman K, Whipp BJ, Koyl SN et al. Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol 1973; 35: 236-243
99 Wasserman K, Whipp BJ, Davis JA. Respiratory physiology of exercise: metabolism, gas exchange, and ventilatory control. Int Rev Physiol 1981; 23: 149-211
100 Hofmann P, Pokan R, von Duvillard SP et al. Heart rate performance curve during incremental cycle ergometer exercise in healthy young male subjects. Med Sci Sports Exerc 1997; 29: 762-768
101 Jones NL, Makrides L, Hitchcock C et al. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985; 131: 700-708
102 Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 1984; 129: 49-S55
103 American College of Sports Medicine. ACSM's Metabolic Calculations Handbook. Baltimore: Lippincott Williams and Wilkins; 2006
104 Rühle KH. Praxisleitfaden der Spiroergometrie. 2.. ed. Stuttgart: Kohlhammer; 2009
105 Cooper B, Storer W. Exercise testing and interpretation. Cambridge: University Press; 2001
106 Froehlicher VF, Myers J, Follanbee WP et al. Exercise and the heart. St. Louis: Mosby; 1993
107 Koulouris NG, Hardavella G. Physiological techniques for detecting expiratory flow limitation during tidal breathing. Eur Respir Rev 2011; 20: 147-155
108 Johnson BD, Weisman IM, Zeballos RJ et al. Emerging concepts in the evaluation of ventilatory limitation during exercise: the exercise tidal flow-volume loop. Chest 1999; 116: 488-503
109 Pepin V, Saey D, Laviolette L et al. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation. COPD 2007; 4: 195-204
110 O'Donnell DE, Banzett RB, Carrieri-Kohlman V et al. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. Proc Am Thorac Soc 2007; 4: 145-168
111 Revill SM, Morgan MD. Biological quality control for exercise testing. Thorax 2000; 55: 63-66
112 Jones NL. Clinical exercise testing. 4.. ed. Saunders; 1997
113 Wilmore JH, Stanforth PR, Turley KR et al. Reproducibility of cardiovascular, respiratory, and metabolic responses to submaximal exercise: the HERITAGE Family Study. Med Sci Sports Exerc 1998; 30: 259-265
114 Roca J, Whipp BJ. Clinical exercise testing. 2.. ed. European Respiratory Society; 1997
115 Wasserman K, Hansen JE, Sue DY et al. Principles of exercise testing and interpretation. 4th. ed. Philadelphia: Lea & Febiger; 2004
116 Schmid A, Schilter D, Fengels I et al. Design and validation of an interpretative strategy for cardiopulmonary exercise tests. Respirology 2007; 12: 916-923
117 Eschenbacher WL, Mannina A. An algorithm for the interpretation of cardiopulmonary exercise tests. Chest 1990; 97: 263-267
118 Killian KJ, Leblanc P, Martin DH et al. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146: 935-940
119 Cotes JE, Zejda J, King B. Lung function impairment as a guide to exercise limitation in work-related lung disorders. Am Rev Respir Dis 1988; 137: 1089-1093
120 O'Donnell DE. Breathlessness in patients with chronic airflow limitation. Mechanisms and management. Chest 1994; 106: 904-912
121 O'Donnell DE, D'Arsigny C, Fitzpatrick M et al. Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. Am J Respir Crit Care Med 2002; 166: 663-668
122 Spiro SG, Hahn HL, Edwards RH et al. An analysis of the physiological strain of submaximal exercise in patients with chronic obstructive bronchitis. Thorax 1975; 30: 415-425
123 Lee YC, Singh B, Pang SC et al. Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. Occup Environ Med 2003; 60: 201-206
124 Lama VN, Martinez FJ. Resting and exercise physiology in interstitial lung diseases. Clin Chest Med 2004; 25: 435-53, v
125 Glaser S, Noga O, Koch B et al. Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis. Respir Med 2009; 103: 317-324
126 Bush A, Busst CM. Cardiovascular function at rest and on exercise in patients with cryptogenic fibrosing alveolitis. Thorax 1988; 43: 276-283
127 Spiro SG, Dowdeswell IR, Clark TJ. An analysis of submaximal exercise responses in patients with sarcoidosis and fibrosing alveolitis. Br J Dis Chest 1981; 75: 169-180
128 Weitzenblum E, Ehrhart M, Rasaholinjanahary J et al. Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases. Respiration 1983; 44: 118-127
129 Gibbons WJ, Levy RD, Nava S et al. Subclinical cardiac dysfunction in sarcoidosis. Chest 1991; 100: 44-50
130 Lainchbury JG, Richards AM. Exercise testing in the assessment of chronic congestive heart failure. Heart 2002; 88: 538-543
131 Arena R, Myers J, Abella J et al. The ventilatory classification system effectively predicts hospitalization in patients with heart failure. J Cardiopulm Rehabil Prev 2008; 28: 195-198
132 Agostoni P, Pellegrino R, Conca C et al. Exercise hyperpnea in chronic heart failure: relationships to lung stiffness and expiratory flow limitation. J Appl Physiol 2002; 92: 1409-1416
133 Leite JJ, Mansur AJ, de Freitas HF et al. Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation. J Am Coll Cardiol 2003; 41: 2175-2181
134 Wensel R, Opitz CF, Anker SD et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 2002; 106: 319-324
135 Janicki JS, Weber KT, Likoff MJ et al. Exercise testing to evaluate patients with pulmonary vascular disease. Am Rev Respir Dis 1984; 129: 93-S95
136 Sun XG, Hansen JE, Oudiz RJ et al. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001; 104: 429-435
137 Vonbank K, Funk GC, Marzluf B et al. Abnormal pulmonary arterial pressure limits exercise capacity in patients with COPD. Wien Klin Wochenschr 2008; 120: 749-755
138 Holverda S, Bogaard HJ, Groepenhoff H et al. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension. Respiration 2008; 76: 160-167
139 Pynnaert C, Lamotte M, Naeije R. Aerobic exercise capacity in COPD patients with and without pulmonary hypertension. Respir Med 2010; 104: 121-126
140 Scheidl SJ, Englisch C, Kovacs G et al. Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients. Eur Respir J 2012; 39: 119-124
141 Sun XG, Hansen JE, Oudiz RJ et al. Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension. Circulation 2002; 105: 54-60
142 Stringer WW, Hansen JE, Wasserman K. Cardiac output estimated noninvasively from oxygen uptake during exercise. J Appl Physiol 1997; 82: 908-912
143 Ting H, Sun XG, Chuang ML et al. A noninvasive assessment of pulmonary perfusion abnormality in patients with primary pulmonary hypertension. Chest 2001; 119: 824-832
144 Yasunobu Y, Oudiz RJ, Sun XG et al. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 2005; 127: 1637-1646
145 Dumitrescu D, Oudiz RJ, Karpouzas G et al. Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing. PLoS One 2010; 5: e14293
146 Sicari R, Nihoyannopoulos P, Evangelista A et al. Stress Echocardiography Expert Consensus Statement--Executive Summary: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur Heart J 2009; 30: 278-289
147 Pellikka PA, Nagueh SF, Elhendy AA et al. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 2007; 20: 1021-1041
148 Grunig E, Weissmann S, Ehlken N et al. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia. Circulation 2009; 119: 1747-1757
149 Ha JW, Choi D, Park S et al. Determinants of exercise-induced pulmonary hypertension in patients with normal left ventricular ejection fraction. Heart 2009; 95: 490-494
150 Lau EM, Manes A, Celermajer DS et al. Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. Eur Heart J 2011; 32: 2489-2498
151 Grunig E, Barner A, Bell M et al. [Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with commentary of the Cologne Consensus Conference 2010]. Dtsch Med Wochenschr 2010; 135: 67-S77
152 McLaughlin VV, Archer SL, Badesch DB et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc. 2009; 53: 1573-1619
153 Bonow RO, Carabello BA, Kanu C et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006; 114: e84-e231
154 Eagle KA, Berger PB, Calkins H et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery – executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105: 1257-1267
155 Poldermans D, Bax JJ, Boersma E et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009; 30: 2769-2812
156 Beattie WS, Abdelnaem E, Wijeysundera DN et al. A meta-analytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging. Anesth Analg 2006; 102: 8-16
157 Kontos MC, Akosah KO, Brath LK et al. Cardiac complications in noncardiac surgery: value of dobutamine stress echocardiography versus dipyridamole thallium imaging. J Cardiothorac Vasc Anesth 1996; 10: 329-335
158 Wijeysundera DN, Beattie WS, Austin PC et al. Non-invasive cardiac stress testing before elective major non-cardiac surgery: population based cohort study. BMJ 2010; 340: b5526
159 Bach DS, Eagle KA. Dobutamine stress echocardiography. Stressing the indications for preoperative testing. Circulation 1997; 95: 8-10
160 Jaroszewski DE, Huh J, Chu D et al. Utility of detailed preoperative cardiac testing and incidence of post-thoracotomy myocardial infarction. J Thorac Cardiovasc Surg 2008; 135: 648-655
161 Agricola E, Picano E, Oppizzi M et al. Assessment of stress-induced pulmonary interstitial edema by chest ultrasound during exercise echocardiography and its correlation with left ventricular function. J Am Soc Echocardiogr 2006; 19: 457-463
162 Chan AK, Govindarajan G, Del Rosario ML et al. Dobutamine stress echocardiography Doppler estimation of cardiac diastolic function: a simultaneous catheterization correlation study. Echocardiography 2011; 28: 442-447
163 Yildirim A, Sedef TF, Pinarli FG et al. Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion. Eur J Echocardiogr 2010; 11: 814-822
164 Herth F, Schulz MR, Manegold C et al. [Usefulness of stress echocardiography for early diagnosis of anthracycline-induced cardiomyopathy]. Pneumologie 2001; 55: 385-389
165 Casaburi R, ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: 1329-1335
166 Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640-2646
167 Meyer-Erkelenz JD, Mosges RW, Sieverts H. [Spiroergometry (cardiopulmonary function under load). Report of the results of the 1979 colloquium in Aachen]. Prax Klin Pneumol 1980; 34: 585-600
168 Ozcan C, Zaret BL. Dobutamine stress test and beta-agonist – a potential concern for nuclear cardiology testing: a case report. Cases J 2009; 2: 7466
169 Olschewski H, Hoeper MM, Borst MM et al. [Diagnosis and therapy of chronic pulmonary hypertension]. Pneumologie 2006; 60: 749-771
170 Agostoni P, Doria E, Galli C et al. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 139: 120-125
171 Seibold H, Bunjes D, Schmidt A et al. Pathophysiological aspects of predominant preload lowering on pulmonary circulation, gas exchange, and the biventricular function in patients with chronic obstructive lung disease. Clin Cardiol 1988; 11: 630-638
172 Blumberg FC, Riegger GA, Pfeifer M. Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise. Chest 2002; 121: 1566-1571
173 Provencher S, Herve P, Sitbon O et al. Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension. Eur Respir J 2008; 32: 393-398
174 Kovacs G, Berghold A, Scheidl S et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 2009; 34: 888-894
175 Badesch DB, Champion HC, Sanchez MA et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S55-S66
176 Opitz CF. Invasive diagnostic evaluation in patients with pulmonary hypertension. Dtsch Med Wochenschr 2010; 135: S78-S86
177 Rosenkranz S, Behr J, Ewert R et al. [Right heart catheterization in pulmonary hypertension]. Dtsch Med Wochenschr 2011; 136: 2601-2616
178 Kovacs G, Maier R, Aberer E et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med 2009; 180: 881-886
179 Steen V, Chou M, Shanmugam V et al. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis. Chest 2008; 134: 146-151
180 Tolle JJ, Waxman AB, Van Horn TL et al. Exercise-induced pulmonary arterial hypertension. Circulation 2008; 118: 2183-2189
181 Kovacs G, Maier R, Aberer E et al. Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure. Arthritis Rheum 2012; 64: 1257-1262
182 Bonderman D, Martischnig AM, Vonbank K et al. Right ventricular load at exercise is a cause of persistent exercise limitation in patients with normal resting pulmonary vascular resistance after pulmonary endarterectomy. Chest 2011; 139: 122-127
183 Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 2010; 137: 39S-51S
184 Hemnes AR, Forfia PR, Champion HC. Assessment of pulmonary vasculature and right heart by invasive haemodynamics and echocardiography. Int J Clin Pract Suppl 2009; 4-19
185 Blanco I, Gimeno E, Munoz PA et al. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med 2010; 181: 270-278
186 Syyed R, Reeves JT, Welsh D et al. The relationship between the components of pulmonary artery pressure remains constant under all conditions in both health and disease. Chest 2008; 133: 633-639
187 Carlsen KH, Anderson SD, Bjermer L et al. Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN. Allergy 2008; 63: 492-505
188 Criee CP, Berdel D, Heise D et al. [Recommendations on spirometry by Deutsche Atemwegsliga]. Pneumologie 2006; 60: 576-584
189 Deutsche Atemwegsliga und Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin. Empfehlungen zur Ganzkörperplethysmographie (Bodyplethysmographie). Dustri Verlag; 2009
190 Joos GF, O'Connor B, Anderson SD et al. Indirect airway challenges. Eur Respir J 2003; 21: 1050-1068
191 Lindemann H, Leupold W. Lungenfunktionsdiagnostik bei Kindern. Kohlhammer; 2003
192 Tancredi G, Quattrucci S, Scalercio F et al. 3-min step test and treadmill exercise for evaluating exercise-induced asthma. Eur Respir J 2004; 23: 569-574
193 Carlsen KH. The breathless adolescent asthmatic athlete. Eur Respir J 2011; 38: 713-720
194 Worth H, Meyer A, Folgering H et al. [Recommendations of the German Respiratory League on sports and physical training for patients with obstructive respiratory tract diseases]. Pneumologie 2000; 54: 61-67
195 Tetzlaff K, Klingmann C, Muth CM et al. Checkliste Tauchtauglichkeit. Stuttgart: Gentner; 2009
196 Balady GJ, Berra KA, Golding LA et al. Exercise prescription for cardiac patients. In: Frankling BA, Whaley MH, Howley ET, editors ACSM´s Guidelines for Exercise Testing and Prescription. Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo: Lippincott, Williams & Wilkins; 2000: 165-169
197 Stilgenbauer F, Reißnecker S, Steinacker JM. Herzfrequenzvorgaben für Ausdauertraining von Herzpatienten. Dtsch Z Sportmed 2003; 53: 228-229
198 Carvalho VO, Mezzani A. Aerobic exercise training intensity in patients with chronic heart failure: principles of assessment and prescription. Eur J Cardiovasc Prev Rehabil 2011; 18: 5-14
199 Simmons DN, Berry MJ, Hayes SI et al. The relationship between HRpeak and VO2peak in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc 2000; 32: 881-886
200 Berry MJ, Woodard CM. Chronic obstructive pulmonary disease. In: Ehrmann JK, Gordon PM, Visich PS, et al., editors Clinical Exercise Physiology. Human Kinetics; 2003: 3339-3366
201 Beauchamp MK, Nonoyama M, Goldstein RS et al. Interval versus continuous training in individuals with chronic obstructive pulmonary disease – a systematic review. Thorax 2010; 65: 157-164
202 Meyer T, Lucia A, Earnest CP et al. A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters – theory and application. Int J Sports Med 2005; 26: 38-S48
203 Friedmann-Bette B. Die Spiroergometrie in der sportmedizinischen Leistungsdiagnostik. Deutsch Z Sportmed 2011; 62: 10-15
204 Friedmann-Bette B. Leistungsdiagnostik und Trainingssteuerung. Therapeutische Umschau 1998; 55: 246-250
205 Deutsche Gesetzliche Unfallversicherung. Berufsgenossenschaftliche Grundsätze für arbeitsmedizinische Vorsorgeuntersuchungen. 5.. ed. Stuttgart: Gentner; 2010
206 Reiterer W. Methodik eines rektangulär-triangulären Belastungstestes. Herz-Kreislauf 1975; 7: 457-462
207 Preisser AM, Ochmann U. [Cardiopulmonary exercise testing in occupational medical fitness examination and assessment]. Pneumologie 2011; 65: 662-670
208 Preisser A, Baur X. [Proposals for updating of the “Reichenhaller leaflet”- Review of recommendations for occupational diseases in Nrn. 1315 (without alveolitis), 4301 and 4302 layout of BKV”]. Pneumologie 2008; 62: 491-493
209 Brutsche MH, Spiliopoulos A, Bolliger CT et al. Exercise capacity and extent of resection as predictors of surgical risk in lung cancer. Eur Respir J 2000; 15: 828-832
210 Win T, Jackson A, Sharples L et al. Cardiopulmonary exercise tests and lung cancer surgical outcome. Chest 2005; 127: 1159-1165
211 Loewen GM, Watson D, Kohman L et al. Preoperative exercise Vo2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. J Thorac Oncol 2007; 2: 619-625
212 Benzo R, Kelley GA, Recchi L et al. Complications of lung resection and exercise capacity: a meta-analysis. Respir Med 2007; 101: 1790-1797
213 Brunelli A, Belardinelli R, Refai M et al. Peak oxygen consumption during cardiopulmonary exercise test improves risk stratification in candidates to major lung resection. Chest 2009; 135: 1260-1267
214 Holden DA, Rice TW, Stelmach K et al. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest 1992; 102: 1774-1779
215 Markos J, Mullan BP, Hillman DR et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989; 139: 902-910
216 Pierce RJ, Copland JM, Sharpe K et al. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med 1994; 150: 947-955
217 Brunelli A, Refai M, Xiume F et al. Performance at symptom-limited stair-climbing test is associated with increased cardiopulmonary complications, mortality, and costs after major lung resection. Ann Thorac Surg 2008; 86: 240-247
218 Koegelenberg CF, Diacon AH, Irani S et al. Stair climbing in the functional assessment of lung resection candidates. Respiration 2008; 75: 374-379
219 Goeckenjan G, Sitter H, Thomas M et al. Prevention, diagnosis, therapy, and follow-up of lung cancer: interdisciplinary guideline of the German Respiratory Society and the German Cancer Society. Pneumologie 2011; 65: 39-59
220 BTS. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56: 89-108
221 Colice GL, Shafazand S, Griffin JP et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132: 161S-177S
222 Brunelli A, Charloux A, Bolliger CT et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009; 34: 17-41
223 Choong CK, Meyers BF, Battafarano RJ et al. Lung cancer resection combined with lung volume reduction in patients with severe emphysema. J Thorac Cardiovasc Surg 2004; 127: 1323-1331
224 Older P, Smith R, Courtney P et al. Preoperative evaluation of cardiac failure and ischemia in elderly patients by cardiopulmonary exercise testing. Chest 1993; 104: 701-704
225 Snowden CP, Prentis JM, Anderson HL et al. Submaximal cardiopulmonary exercise testing predicts complications and hospital length of stay in patients undergoing major elective surgery. Ann Surg 2010; 251: 535-541
226 Fleisher LA, Beckman JA, Brown KA et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007; 116: e418-e499
227 O'Donnell DE, Voduc N, Fitzpatrick M et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004; 24: 86-94
228 O'Donnell DE, Fluge T, Gerken F et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-840
229 Maltais F, Hamilton A, Marciniuk D et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 2005; 128: 1168-1178
230 Emtner M, Porszasz J, Burns M et al. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med 2003; 168: 1034-1042
231 Palange P, Valli G, Onorati P et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. J Appl Physiol 2004; 97: 1637-1642
232 Schonhofer B, Dellweg D, Suchi S et al. Exercise endurance before and after long-term noninvasive ventilation in patients with chronic respiratory failure. Respiration 2008; 75: 296-303
233 Ferguson GT, Fernandez E, Zamora MR et al. Improved exercise performance following lung volume reduction surgery for emphysema. Am J Respir Crit Care Med 1998; 157: 1195-1203
234 Hopkinson NS, Toma TP, Hansell DM et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med 2005; 171: 453-460
235 Come CE, Divo MJ, San Jose ER et al. Lung deflation and oxygen pulse in COPD: results from the NETT randomized trial. Respir Med 2012; 106: 109-119
236 Sciurba FC, Ernst A, Herth FJ et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363: 1233-1244
237 Slebos DJ, Klooster K, Ernst A et al. Bronchoscopic Lung Volume Reduction Coil treatment of patients with severe heterogeneous emphysema. Chest 2011;
238 Cote CG, Pinto-Plata VM, Marin JM et al. The modified BODE index: validation with mortality in COPD. Eur Respir J 2008; 32: 1269-1274
239 Oga T, Nishimura K, Tsukino M et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003; 167: 544-549
240 Chua R, Keogh AM, Byth K et al. Comparison and validation of three measures of quality of life in patients with pulmonary hypertension. Intern Med J 2006; 36: 705-710
241 Barst RJ, Rubin LJ, Long WA. The Primary Pulmonary Hypertension Study Group et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296-302
242 Snow JL, Kawut SM. Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy. Clin Chest Med 2007; 28: 75-89, viii
243 Sitbon O, Humbert M, Nunes H et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002; 40: 780-788
244 Provencher S, Sitbon O, Humbert M et al. Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. Eur Heart J 2006; 27: 589-595
245 Diller GP, Dimopoulos K, Okonko D et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 2005; 112: 828-835
246 Groepenhoff H, Vonk-Noordegraaf A, Boonstra A et al. Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc 2008; 40: 1725-1732
247 Giardini A, Hager A, Lammers AE et al. Ventilatory efficiency and aerobic capacity predict event-free survival in adults with atrial repair for complete transposition of the great arteries. J Am Coll Cardiol 2009; 53: 1548-1555
248 Wensel R, Francis DP, Meyer FJ et al. Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension. Int J Cardiol 2012; Apr 9 epub ahead of print
249 Kawut SM, Horn EM, Berekashvili KK et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Am J Cardiol 2005; 95: 199-203
250 Muller J, Christov F, Schreiber C et al. Exercise capacity, quality of life, and daily activity in the long-term follow-up of patients with univentricular heart and total cavopulmonary connection. Eur Heart J 2009; 30: 2915-2920
251 Trojnarska O, Gwizdala A, Katarzynski S et al. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease. Cardiol J 2009; 16: 133-141
252 Opitz CF, Blindt R, Blumberg F et al. Pulmonary hypertension: Hemodynamic evaluation. Updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol 2011; 154: 13-S19
253 Goldberg DJ, French B, McBride MG et al. Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation 2011; 123: 1185-1193
254 Giardini A, Balducci A, Specchia S et al. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J 2008; 29: 1681-1687
255 Wax D, Garofano R, Barst RJ. Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension. Chest 1999; 116: 914-920
256 Wensel R, Opitz CF, Ewert R et al. Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension. Circulation 2000; 101: 2388-2392
257 Affuso F, Palmieri EA, Di Conza J. Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension. Int J Cardiol 2006; 108: 429-431
258 Mikhail GW, Prasad SK, Li W et al. Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. Eur Heart J 2004; 25: 431-436
259 Gilbert C, Brown MC, Cappelleri JC et al. Estimating a minimally important difference in pulmonary arterial hypertension following treatment with sildenafil. Chest 2009; 135: 137-142
260 Oudiz RJ, Roveran G, Hansen JE et al. Effect of sildenafil on ventilatory efficiency and exercise tolerance in pulmonary hypertension. Eur J Heart Fail 2007; 9: 917-921
261 Hoeper MM, Taha N, Bekjarova A et al. Bosentan treatment in patients with primary pulmonary hypertension receiving nonparenteral prostanoids. Eur Respir J 2003; 22: 330-334
262 Riley MS, Porszasz J, Engelen MP et al. Responses to constant work rate bicycle ergometry exercise in primary pulmonary hypertension: the effect of inhaled nitric oxide. J Am Coll Cardiol 2000; 36: 547-556
263 Nagaya N, Kangawa K. Adrenomedullin in the treatment of pulmonary hypertension. Peptides 2004; 25: 2013-2018
264 Guazzi M, Adam V, Conraads V et al. EACPR/AHA Joint Scientific Statement. Clinical Accomendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 2012; epub September 5
265 Dumitrescu D, Rosenkranz S. Atlas Spiroergometrie und Pulmonale Hypertonie. 1.. Aufl. Freiburg: Jungbluth; 2011